Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00251030 · ClinicalTrials.gov registry record · Phase 4
A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects
A Phase 4 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00251030 is a Phase 4 study that has completed, run by Pfizer. The registered enrollment target is 20 participants.
The verdict
NCT00251030, a Phase 4 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
To estimate the effects of omeprazole on the pharmacokinetics of nelfinavir in healthy subjects
Interventions
- DRUG Nelfinavir and Omeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-11 |
| Est. Completion | 2006-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00251030
The ClinicalTrials.gov registry entry for NCT00251030 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nelfinavir and Omeprazole is the first listed.
NCT00251030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00251030 about?
NCT00251030 is a clinical study titled "A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects". To estimate the effects of omeprazole on the pharmacokinetics of nelfinavir in healthy subjects
What is the current status of trial NCT00251030?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2005-11. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00251030?
The interventions under investigation include: Nelfinavir and Omeprazole (DRUG).
Who is sponsoring clinical trial NCT00251030?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.